Influence Of thioctic acid on oxidative stress and microalbuminuria in patients with early diabetic nephropathy

Giacco F, Brownlee M. Oxidative stress and diabetic complications [J]. Circulation Research, 2010(9):1058.

Vasavada N, Agarwal R. Role of oxidative stress in diabetic nephropathy [J]. Advances in Chronic Kidney Disease, 2005(2):146.

American Diabetes Association. Standards of Medical Care in Diabetes-2009 [J]. Diabetes Care, 2009, (Suppl 1):S13.

Sun YM, Su Y, Li J. Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy [J]. Biochemical and Biophysical Research Communications, 2013(4):359.

Wads J, Makino H. Inflammation and the pathogenesis of diabetic nephropathy [J]. Clinical Science (London), 2013(3):139.

Brownlee M. The pathobiology of diabetic complications, a unifying mechanism [J]. Diabetes, 2005(6):1615.

Hos, seini A, Abdollahi M. Diabetic neuropathy and oxidative stress:therapeutic perspectives [J]. Oxidative Medicine and Cellular Longevity, 2013.168039.

Varkonyi T, Putz Z, Keresztes K. Current options and perspectives in the treatment of diabetic neuropathy [J]. Current Pharmaceutical Design, 2013, (27):4981.

倪正平, 祝群. 硫辛酸对2型糖尿病合并颈动脉硬化患者氧化应激指标和内皮素的影响 [J]. 中国医师进修杂志, 2011, (19):47.doi: 10.3760/cma.j.issn.1673-4904.2011.19.018.

周建华, 陈景斌, 雷龙涛. 硫辛酸治疗早期糖尿病肾病的临床观察 [J]. 中国现代医药杂志, 2013(2):31.